Rattlesnake Antivenin Articles
Fougera's CroFab celebrates 5th anniversary
22 August 2005
Protherics sees profit for six-month period
20 December 2004
Protherics reports first year of profit for 2003
31 May 2004
Protherics charms profit from snake venom drug
8 December 2003
Protherics acquires Enact and makes L3M placing
12 May 2003
Protherics now in profit
3 June 2002
Protherics' angiotensin vaccine promising
1 April 2002
Protherics launches DigiFab in USA
11 March 2002
Protherics cuts loss, readies CroFAb for US launch
14 December 2000
Showing 1-10 of 10 articles
- 1
- Encouraging results with Sangamo's SB-728-T in HIV treatment
- Bristol-Myers' data on Yervoy and nivolumab causes a stir
- AstraZeneca plans to move three cancer drug candidates into Ph III
- Sanofi prepares for regulatory filing of MF candidate on positive JAKARTA study results
- Merck Serono Ph III trial of L-BLP25 fails endpoint in NSCLC
